Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Crisaborole in Mild to Moderate Atopic Dermatitis
NCT07519174Not yet recruiting
- Sponsor
- Foundation University Islamabad
- Start
- Jun 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD) (2 arms), sponsored by Foundation University Islamabad. Primary endpoint: Eczema Area and Severity Index at 8 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07519174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519174.